TTI1 promotes non‐small‐cell lung cancer progression by regulating the mTOR signaling pathway

The role of TELO2‐interacting protein 1 (TTI1) in the progression of several types of cancer has been reported recently. The aim of this study was to estimate the expression and potential value of TTI1 in non‐small‐cell lung cancer (NSCLC) patients. The expression of TTI1 and its prognostic value in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling‐Xian, Yang, Xin, Wu, Zhi‐Bo, Liao, Zhong‐Min, Wang, Ding‐Guo, Chen, Shi‐Wei, Lu, Feng, Wu, Yong‐Bing, Zhu, Shu‐Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986064/
https://www.ncbi.nlm.nih.gov/pubmed/36403197
http://dx.doi.org/10.1111/cas.15668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986064/
https://www.ncbi.nlm.nih.gov/pubmed/36403197
http://dx.doi.org/10.1111/cas.15668

Ejemplares similares